Literature DB >> 12378623

Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues.

Zhao-Shan Niu1, Bo-Kian Li, Mei Wang.   

Abstract

AIM: To investigate the possible roles of p53 and C-myc genes in the primary hepatocellular carcinogenesis and the relationship between the liver hyperplastic nodule (LHN) and hepatocellular carcinoma(HCC).
METHODS: The expression of p53 and C-myc genes was detected immunohistochemically in 73 and 60 cases of HCC and pericarcinomatous tissues, respectively.
RESULTS: The positive expression of p53 in HCC was significantly higher than that in pericarcinomatous tissues (P<0.05). In pericarcinomatous tissues, the p53 expression was observed only in LHN, but not in liver cirrhosis (LC) and normal liver tissues. The positive expression rate of C-myc in HCC or LHN was significantly higher than that in LC or normal liver tissues (P<0.05 and P<0.01), however, no significant difference was found between HCC and LHN (P>0.05). The positive expression rate of p53 and C-myc in HCC was correlated with the histological differentiation, that in the poorly differentiated was significantly higher than that in well differentiated samples (P<0.05).
CONCLUSION: The overexpression of p53 and C-myc genes might play a role in the carcinogenesis of HCC; And LHN seems a preneoplastic lesion related to hepatocarcinogenesis; No evidence supports that LC contribute directly to the hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378623      PMCID: PMC4656568          DOI: 10.3748/wjg.v8.i5.822

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  46 in total

1.  Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks.

Authors:  C Martins; M A Kedda; M C Kew
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma.

Authors:  X D Zhou; Z Y Tang; B H Yang; Z Y Lin; Z C Ma; S L Ye; Z Q Wu; J Fan; L X Qin; B H Zheng
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

3.  p53: The Challenge of Linking Basic Science and Patient Management.

Authors: 
Journal:  Oncologist       Date:  1998

4.  Effect of HCV infection on expression of several cancer-associated gene products in HCC.

Authors:  Jian-Min Yang; Rong-Quan Wang; Bao-Guo Bu; Zi-Cheng Zhou; Dian-Chun Fang; Yuan-Hui Luo
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

5.  Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.

Authors:  M F Yuen; P C Wu; V C Lai; J Y Lau; C L Lai
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

Review 6.  The p53 pathway.

Authors:  C Prives; P A Hall
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

7.  [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma].

Authors:  L Shen; D Qui; J Fang
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1997-05

8.  The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas.

Authors:  H Sugo; S Takamori; K Kojima; T Beppu; S Futagawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

9.  Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.

Authors:  S Kawate; T Fukusato; S Ohwada; A Watanuki; Y Morishita
Journal:  Oncology       Date:  1999       Impact factor: 2.935

10.  Close correlation between a p53 or hMSH2 gene mutation in the tumor and survival of hepatocellular carcinoma patients.

Authors:  M Yano; T Asahara; K Dohi; T Mizuno; K S Iwamoto; T Seyama
Journal:  Int J Oncol       Date:  1999-03       Impact factor: 5.650

View more
  12 in total

1.  Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.

Authors:  Xin-Juan Kong; Yu-Hu Song; Ju-Sheng Lin; Huan-Jun Huang; Nan-Xia Wang; Nan-Zhi Liu; Bin Li; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.

Authors:  Wen-Sheng Huang; Jian-Ping Wang; Ting Wang; Jie-Yu Fang; Ping Lan; Jin-Ping Ma
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

3.  Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948.

Authors:  Wen-Sheng Huang; Tian-Bao Wang; Yao He; Yu-Jun Chen; Shi-Long Zhong; Min Tan
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

4.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.

Authors:  Filiz Türe Ozdemir; Arzu Tiftikci; Seda Sancak; Fatih Eren; Veysel Tahan; Hakan Akın; Feyza Gündüz; Ala Eldeen Kedrah; Yücel Ustündağ; Erol Avşar; Nurdan Tözün; Osman Ozdoğan
Journal:  J Gastrointest Cancer       Date:  2010-09

6.  Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.

Authors:  Shao-Shan Wang; Ti Zhang; Xi-Lu Wang; Li Hong; Qing-Hui Qi
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

7.  Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells.

Authors:  Bin-Wen Wu; Yuan Wu; Jia-Long Wang; Ju-Sheng Lin; Shu-Yu Yuan; Ai Li; Wu-Ren Cui
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

8.  Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.

Authors:  Ming-Yi Li; Hua Deng; Jia-Ming Zhao; Dong Dai; Xiao-Yu Tan
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

9.  Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection.

Authors:  Jun Cui; Bao-Wei Dong; Ping Liang; Xiao-Ling Yu; De-Jiang Yu
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

10.  Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.

Authors:  Su-Xia Liu; Wen-Sheng Sun; Ying-Lin Cao; Chun-Hong Ma; Li-Hui Han; Li-Ning Zhang; Zhen-Guang Wang; Fa-Liang Zhu
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.